This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Shifts in income, goals, or family needs make change necessary; use this guide to justify and implement thoughtful budget updates.
26,233 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A hypothetical move where Paramount aligns with Warner Bros. Discovery would ripple through streaming, financing, and...
The Stanford board sold HeartFlow shares for about $8.5 million, triggering questions about insider signals. This art...
NVIDIA stock has fallen over the past month, triggering worries about headlines and momentum. This article breaks dow...
When a CFO sells company shares worth millions, investors naturally wonder what it means for stock risk and future re...
A sizable move in the First Trust QTEC fund has traders buzzing. Is the sale a warning sign for overheated AI stocks ...
A large stake exit sent shockwaves through a payments stock, pulling it down by about half from its highs. This artic...
A legendary Knicks star offers a blunt lens on staying disciplined in investing. This article turns that mindset into...
Volatility is shaping a smarter approach to investing. Discover three growth stocks worth $5,000 and how to build a f...
Investors have been watching does planet labs stock slide for months. This guide breaks down the drivers, the risks, ...
This week brought a notable pullback in AI hardware names, including CoreWeave. Read a clear, practical look at what ...
A major institutional move has trimmed a niche ETF position. Perritt Capital Management exited its Vanguard Internati...